On May 16, the “LiverCare – Hong Kong 10 Million Liver Scans Program” jointly initiated and supported by Eieling Technology Limited, Hong Kong liver disease experts, Hong Kong Polytechnic University, Hong Kong Trade Development Council, Hong Kong Science Park, Hong Kong Liver Life Foundation, Hong Kong HSBC, Hong Kong Pacific Insurance, Xizhou International Co., Ltd. and many high-end clinics was officially launched at the Asian Medical Health Summit. During the event, the Secretary for Health and Medical Affairs of the Hong Kong Special Administrative Region Government, Mr. Lo Chung-mau, accompanied by Ms. Fang Shunwen, President of the Hong Kong Trade Development Council, visited the Technology booth and expressed his concern for Liverscan and this ” LiverCare – Hong Kong 10 Million Liver Scans Program “.
It is planned to carry out early screening activities for liver disease covering 10 million people in Hong Kong, promote the importance of liver disease prevention and treatment, encourage the public to actively participate in health examinations, reveal and treat liver disease as early as possible, and protect the health of citizens. Promote in-depth cooperation among all sectors in Hong Kong in the prevention, diagnosis and management of liver disease, form a closer prevention and treatment network through the synergy of cross-field professional forces, and enhance Hong Kong’s influence and status in the field of global liver disease prevention and treatment. This ” LiverCare ” plan not only reflects the high attention paid by Hong Kong society to public health, but also marks a solid step forward in Hong Kong’s integration of multi-faceted resources to jointly respond to health challenges.
Liver Disease Background
According to the “Hong Kong Viral Hepatitis Action Plan 2020-2024”, in Hong Kong, it is estimated that about 540,000 people are infected with chronic hepatitis B and 22,000 people are infected with chronic hepatitis C. Chronic hepatitis infection often remains asymptomatic for many years until it develops into cirrhosis and liver cancer, thus missing the best time to seek and receive treatment in a timely manner.
Launch Ceremony of the LiverCare Program
Opening Speech
The LiverCare Program
Background
Professor Seto, Wai Kay Walter: “According to statistics from the Global Cancer Observatory, liver cancer ranks second in cancer mortality in East Asia in 2020. By 2040, the number of liver cancer patients in the Asia-Pacific region will exceed 995,000.” There is still a long way to go to eliminate HBV. Timely HBV screening can effectively reduce liver-related mortality. Among them, Liverscan, as the most ideal solution for liver fibrosis screening, has the characteristics of immediate care, painless and non-invasive,accurate and portable, which can effectively lower the threshold for treatment and effectively control the risk of liver disease. It has diversified application scenarios and can provide early screening of liver disease for various institutions and patients.”
PolyU’s innovative and entrepreneurial
development in the medical field
Professor Zhao Ruheng said: “As a start-up company supported by PolyU, Eieling Technology Limited has successfully transformed Liverscan into a product with a positive impact on society thanks to the patent licensing strategy and the introduction of investors and industry resources. In addition, PolyU will fully support the ” LiverCare ” program in Hong Kong to be promoted in the PolyU Health Care Office, conduct liver disease screening for full-time faculty and staff of the university, follow up for a two-year study and collect a large amount of data to study the importance of balanced diet, continuous exercise and regular liver disease screening for monitoring liver disease.
Liver disease screening technology
Liverscan was born
Professor Zheng Yongping: “According to relevant literature, “27% of Hong Kong adults are affected by NAFLD, and 61% of obese subjects suffer from NAFLD. In this context, in order to solve this serious social problem, the palm-sized Liverscan with integrated intelligent algorithms was born. We hope to reduce hospital costs and shorten patient testing time through Liverscan, while greatly improving the accuracy of testing, so that liver bomb testing and screening procedures can enter the community and be applied in more scenarios, so that liver assessment can be truly popularized.”
Speech by the guest of the LiverCare Program
Dr. Liu Siya, Senior Director of Translational Research and Development Institute of Hong Kong Science and Technology Parks Corporation
delivered a speech for the ” LiverCare ” program
Ms. Luo Yongqiu, Chairman of Hong Kong Liver Life Foundation
delivered a speech for the ” LiverCare ” program
Mr. Liu Huiping, Vice President of Hong Kong Trade Development Council
delivered a speech for the ” LiverCare ” program
Ribbon-cutting ceremony
Hong Kong LiverCare Program officially
launched
The successful holding of this launching ceremony not only laid a solid foundation for the follow-up work of the ” LiverCare ” Program, but also demonstrated the attention and support of all sectors of society for the cause of liver health.
In the future, the ” LiverCare ” Program will continue to increase the intensity of popular science publicity, promote the popularization and application of liver disease screening technology, and provide more patients with timely and accurate diagnosis and treatment services. Let us work together to contribute to the cause of liver health!
This LiverCare – Hong Kong 10 Million Liver Scans Program ” is not only aimed at providing patients with timely and accurate liver disease testing services, but also strives to create a model of health management in Hong Kong. This screening activity will rely on the advanced Liverscan wireless liver bomb technology, and through the Liverscan empowerment service process to increase social participation and form an efficient and sustainable liver disease early screening model. From education, scientific research, clinical treatment to policy formulation, we will integrate resources to jointly promote the popularization of health knowledge and the improvement of health awareness. Through the close cooperation of government departments, academic institutions, non-governmental organizations and social capital, we will achieve effective control of chronic liver disease and complications, further optimize and innovate screening strategies, and make it a platform for early diagnosis and prevention of other major diseases. The best practice of prevention. The plan is expected to improve the service level of Hong Kong’s medical and health field, and will also have a positive and far-reaching impact on the health management model in the entire Asia-Pacific region and even the world.
Here, we call on every citizen who cares about health to actively participate in the early screening of liver disease. At the same time, we also look forward to the continued attention and support from all walks of life, and sincerely invite you to jointly promote the innovative development of Hong Kong’s public health.
·
Join the “Caring for the Liver” program to protect the liver health of the people
Welfare project: Join the LiverCare ” Program and become a ” LiverCare ” initiator to enjoy a 50% discount on equipment sales! (Return for five consecutive years)
Public welfare responsibility: The initiator of ” the LiverCare ” needs to undertake a five-year public welfare screening project of 200 people/year;
Project period: May 17, 2024 to May 16, 2029.
Professor Zheng Yongping from the Hong Kong Polytechnic University was invited to Nanjing to conduct academic exchanges with Professor Li Jie’s team from Nanjing Drum Tower Hospital
On November 28, 2024, Professor Li Jie’s team from Nanjing Drum Tower Hospital exchanged views…
Media Focus | Professor Zheng Yongping is a guest on HOY Information Channel (Hong Kong Free TV News Financial Information Channel)
On November 30, 2024, Professor Zheng Yongping, the founding director of the Department of Biomedical…
Perfect ending | Eieling Technology shines at the 2024 Radiological Society of North America (RSNA)
From 1st to 5th Dec 2024, the Radiological Society of North America (RSNA) grandly opened…
RSNA Live Report: Eieling Technology Takes You to Explore the Exhibition
On 1st Dec 2024, RSNA (North American Society of Radiology) grandly opened in Chicago, USA. As the world’s largest medical imaging exhibition, RSNA 2024 brings together the latest in technology and innovation with the industry’s leading manufacturers, suppliers, and developers. At this exhibition, Eieling Technology will share with you the excellent accuracy and high efficiency of the Liverscan Portable Transient Elastography (TE) system in detecting liver diseases. Let us explore and witness the latest achievements and technological breakthroughs in the field of medical imaging！
AASLD concluded successfully, Liverscan attracted great attention
On November 19, 2024, the American Association for the Study of Liver Diseases (AASLD) came…
Eieling Technology Limited Debuts at AASLD
Promote liver disease prevention and treatment, protect your liver health From November 15 to 19,…